Loading...
Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
OBJECTIVE: To seek efficient aldose reductase inhibitors (ARIs) with excellent in vitro and in vivo biological activities against rat galactosemic cataract. METHODS: The method was firstly optimized to screen strong ARIs from nonoriented synthetic compounds and natural extracts. Then, diosgenin was...
Na minha lista:
| Udgivet i: | J Diabetes Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5605930/ https://ncbi.nlm.nih.gov/pubmed/29038789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7309816 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|